+ Site Statistics
References:
54,258,434
Abstracts:
29,560,870
PMIDs:
28,072,757
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Serum levels of 1-84 and 7-84 parathyroid hormone in predialysis patients with chronic renal failure measured by the intact and bio-PTH assay



Serum levels of 1-84 and 7-84 parathyroid hormone in predialysis patients with chronic renal failure measured by the intact and bio-PTH assay



Nephron. Clinical Practice 102(3-4): C108-C114



The intact parathyroid hormone (PTH) assay detects both PTH(1-84) and the PTH(7-84)-like fragment, which is reported to be an antagonist of the biological action of PTH(1-84). It is debatable which of the two assays is clinically more useful, the intact or bio-PTH assay, the latter of which only detects PTH(1-84). It is also unknown whether serum levels of the PTH(7-84)-like fragment have clinical significance. Serum PTH concentrations in 104 predialysis patients with chronic renal failure (CRF; serum creatinine 3.53 +/- 1.93; 62 males and 42 females; 61.0 +/- 11.5 years old) were measured using both the intact and bio-PTH assays, and the concentration of the PTH(7-84)-like fragment was calculated by subtracting bio-PTH from intact PTH. Three bone formation and three bone resorption markers were measured simultaneously. The PTH values measured using the two assays were strongly positively correlated (r = 0.959, p < 0.0001), and were also significantly positively correlated with the three bone formation and three bone resorption markers to a similar degree. The PTH(7-84)-like fragment was significantly positively correlated with both the intact and bio-PTH (r = 0.855, p < 0.0001 for intact PTH; r = 0.672, p < 0.0001 for bio-PTH), and was also significantly positively correlated with each of the six bone metabolism markers. There is no significant relationship between the bio-PTH/PTH(7-84)-like fragment ratio and clinical parameters including bone metabolic markers. From the strong relationship between the two assays, and the similar degree of the relationship between each PTH assay and each of the six bone metabolism markers, it is considered that the bio-PTH and intact PTH assays have similar clinical significance in predialysis CRF patients. Serum levels of the PTH(7-84)-like fragment seem to increase as serum PTH(1-84) increases. The results suggest that the serum PTH(7-84)-like fragment has little specific clinical effect on bone metabolism, even when assessed by the ratio of bio-PTH/PTH(7-84)-like fragment.

Please choose payment method:






(PDF emailed within 0-6 h: $19.90)

Accession: 050289337

Download citation: RISBibTeXText

PMID: 16286785

DOI: 10.1159/000089668


Related references

Serum levels of 1-84 and 7-84 parathyroid hormone in predialysis patients with chronic renal failure measured by the intact and bio-PTH assay. Nephron Clinical Practice 102(3-4): C108-C114, 2006

Two-site immunoradiometric intact parathyroid hormone assay versus C-terminal parathyroid hormone in predicting osteodystrophic bone lesions in predialysis chronic renal failure. Journal of Laboratory and Clinical Medicine 122(1): 103-109, 1993

Serum intact parathyroid hormone concentration measured by a two-site immunoradiometric assay in normal subjects and patients with various parathyroid disorders. Endocrinologia Japonica 39(1): 115-120, 1992

Effect of blood purification on plasma levels of intact parathyroid hormone in patients with chronic renal failure. Di 1 Jun Yi Da Xue Xue Bao 24(2): 234-235, 2004

Interrelationship between haemodynamic state and serum intact parathyroid hormone levels in patients with chronic heart failure. Heart 99(2): 111-115, 2013

Differences between serum and plasma for intact parathyroid hormone measurement in patients with chronic renal failure in routine clinical practice. Journal of Clinical Pathology 58(9): 1000-1001, 2005

Vitamin D receptor polymorphism and intact PTH levels in patients with chronic renal failure in predialysis. European Journal of Human Genetics 6(SUPPL 1): 46-47, 1998

Correlations between serum intact parathyroid hormone (PTH) and N-terminal-probrain natriuretic peptide levels in elderly patients with chronic heart failure (CHF). Archives of Gerontology and Geriatrics 60(2): 359-365, 2015

Comparison of Intact parathyroid hormone levels of hemodialysis patients measured by two laboratories and with the Scantibodies assay. Journal of the American Society of Nephrology 13(Program and Abstracts Issue): 753A, 2002

Influence of keto acids on serum parathyroid hormone levels in patients with chronic renal failure. Clinical Nephrology 20(4): 212-215, 1983

Correlation among levels of skeletal alkaline phosphatase measured by a new immunoradiometric assay and intact PTH and other biochemical markers of bone turnover in patients with chronic renal failure. Calcified Tissue International 52(SUPPL 1): S6, 1993

Clinical significance of serum levels of carboxyl terminal parathyroid hormone and intact parathyroid hormone measured by radio immunoassays. Journal of Nuclear Medicine 23(5): P40, 1982

Influence of vitamin d treatment on serum levels of parathyroid hormone fragments in patients with chronic renal failure. Norman, A Al (ed.). Vitamin D And Problems Related To Uremic Bone Disease. Proceedings Of The Second Workshop. Wiesbaden, West Germany, Oct. 27-30, . Xxiv 779p. Illus. Walter De Gruyter: Berlin, West Germany; New York, N.y., U.s.a. ISBN 3-11-005775-1: 629-633, 1975

Evaluation of IDS-iSYS intact parathyroid hormone (iPTH) and comparison to Siemens Advia Centaur iPTH assay in chronic renal failure patients and in controls. Clinical Laboratory 58(5-6): 403-410, 2012

Intact parathyroid hormone levels as indicator of bone metabolism in chronic renal failure. Acta Endocrinologica Supplementum64: 12-13, 1984